FindTrial
Sign In

Evaluating the role of WBC scintigraphy in monitoring response on infection treatment of prosthetic joint infection

Evaluating the role of WBC scintigraphy in monitoring response on infection treatment of prosthetic joint infection - WBC scan in infected prosthetic joints

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON43167
Enrollment
40
Registered
2018-10-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prosthetic joint infection

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients >= 18 years, who undergo a 2-stage revision surgery (with a short or long-interval) because of an infected prosthesis of the knee or hip. The indication for a 2-stage revision surgery, as well as the decision for a short or long interval, depend on several (clinical) parameters and is made by a multidisciplinary expert team.

Exclusion criteria

Exclusion criteria: Patients

Design outcomes

Primary

MeasureTime frame
The number of re-infections of a prosthetic joint one year after reimplantation. In the cases with a relapse of infection (caused by the same micro-organism(s)), the diagnostic value of the WBC scintigraphy in monitoring the response of infection treatment will be evaluated to define if WBC scintigraphy can help in deciding when to perform the reimplantation.—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)